News

Ozempic Maker’s Plight Shows Managing Markets Counts Too
When it was riding high, Novo Nordisk could have done M&A to reduce its dependence on obesity treatments. It didn’t.
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run
It's been a wild first half of the year for stocks in 2025, but finding the right companies for your portfolio is a very ...
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS ...
BusinessMirror17h
Denmark’s economy runs on Novo, will the drugmaker’s troubles slim it down?
Denmark’s status as one of the few countries in Europe with an expanding economy rests in part on the success of its homegrown hero, Novo Nordisk A/S. Thanks to the pharmaceutical giant’s astronomical ...
What To Expect in Markets This Week: Earnings From Palantir, AMD, McDonald’s and More
Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.